ECO 2025
12 - 15 May 2026
Expanding frontiers in cardiometabolic care with amylin-based therapies
Meeting description
2:58
Wednesday, 13 May 2026
13:45 - 13:50
(TRT)
Setting the scene: defining the need for amylin
Carel le Roux
13:50 - 14:10
(TRT)
Like a phoenix from the ashes: reviving amylin biology for clinical impact
Gema Frühbeck, Anna Secher
14:10 - 14:30
(TRT)
CagriSema: from early-phase evidence to REDEFINing obesity care
Kirsi Pietiläinen
14:30 - 14:40
(TRT)
Zenagamtide (amycretin): a new chapter in amylin-based therapies
Matthias Blüher
14:40 - 15:00
(TRT)
Looking ahead: the potential role of amylin-based therapies in obesity care
Donna Ryan
15:00 - 15:15
(TRT)
Looking ahead: where do we go next?
Carel le Roux, Gema Frühbeck, Anna Secher, Kirsi Pietiläinen, Matthias Blüher, Donna Ryan
Keywords